Profile | GDS4284 / 212448_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 145.424 | 44 |
GSM687648 | Patient 402 control | 167.226 | 46 |
GSM687653 | Patient 403 control | 86.6041 | 33 |
GSM687658 | Patient 404 control | 84.7419 | 31 |
GSM687663 | Patient 411 control | 112.269 | 35 |
GSM687668 | Patient 422 control | 83.5099 | 31 |
GSM687673 | Patient 424 control | 232.516 | 50 |
GSM687678 | Patient 425 control | 191.776 | 46 |
GSM687683 | Patient 427 control | 46.9314 | 21 |
GSM687688 | Patient 428 control | 336.535 | 58 |
GSM687695 | Patient 441 control | 101.081 | 26 |
GSM687699 | Patient 443 control | 208.562 | 46 |
GSM687704 | Patient 444 control | 348.326 | 58 |
GSM687707 | Patient 448 control | 62.2821 | 23 |
GSM687712 | Patient 449 control | 31.5219 | 17 |
GSM687719 | Patient 450 control | 57.4674 | 22 |
GSM687724 | Patient 451 control | 43.7337 | 20 |
GSM687728 | Patient 452 control | 133.954 | 38 |
GSM687646 | Patient 401 treated 24h | 41.5393 | 21 |
GSM687649 | Patient 402 treated 24h | 83.2718 | 33 |
GSM687665 | Patient 411 treated 24h | 142.851 | 39 |
GSM687651 | Patient 402 treated 4 weeks | 184.273 | 46 |
GSM687667 | Patient 411 treated 4 weeks | 55.1569 | 24 |
GSM687670 | Patient 422 treated 24h | 84.2176 | 30 |
GSM687671 | Patient 422 treated 4 weeks | 14.3169 | 9 |
GSM687654 | Patient 403 treated 24h | 136.408 | 43 |
GSM687675 | Patient 424 treated 24h | 83.2241 | 29 |
GSM687685 | Patient 427 treated 24h | 32.9859 | 18 |
GSM687656 | Patient 403 treated 4 weeks | 188.064 | 49 |
GSM687677 | Patient 424 treated 4 weeks | 149.031 | 43 |
GSM687687 | Patient 427 treated 4 weeks | 31.999 | 19 |
GSM687692 | Patient 428 treated 4h | 183.34 | 46 |
GSM687716 | Patient 449 treated 4h | 41.0468 | 20 |
GSM687722 | Patient 450 treated 4h | 91.7211 | 30 |
GSM687680 | Patient 425 treated 24h | 142.735 | 41 |
GSM687690 | Patient 428 treated 24h | 172.925 | 46 |
GSM687700 | Patient 443 treated 24h | 133.243 | 32 |
GSM687705 | Patient 444 treated 24h | 334.929 | 59 |
GSM687714 | Patient 449 treated 24h | 96.1177 | 35 |
GSM687721 | Patient 450 treated 24h | 301.59 | 53 |
GSM687682 | Patient 425 treated 4 weeks | 247.293 | 53 |
GSM687694 | Patient 428 treated 4 weeks | 212.107 | 51 |
GSM687702 | Patient 443 treated 4 weeks | 158.466 | 41 |
GSM687718 | Patient 449 treated 4 weeks | 34.9972 | 18 |
GSM687723 | Patient 450 treated 4 weeks | 108.114 | 34 |
GSM687661 | Patient 404 treated 4h | 112.758 | 36 |
GSM687710 | Patient 448 treated 4h | 226.521 | 51 |
GSM687726 | Patient 451 treated 4h | 53.9231 | 22 |
GSM687730 | Patient 452 treated 4h | 539.181 | 58 |
GSM687660 | Patient 404 treated 24h | 69.8317 | 24 |
GSM687697 | Patient 441 treated 24h | 391.879 | 57 |
GSM687709 | Patient 448 treated 24h | 173.344 | 44 |
GSM687725 | Patient 451 treated 24h | 61.9001 | 22 |
GSM687729 | Patient 452 treated 24h | 69.7735 | 22 |
GSM687727 | Patient 451 treated 4 weeks | 33.1131 | 15 |
GSM687731 | Patient 452 treated 4 weeks | 116.546 | 34 |